Sirisha M Cheedipudi1, Scot J Matkovich2, Cristian Coarfa3, Xin Hu4, Matthew J Robertson3, Mary Sweet5, Matthew Taylor5, Luisa Mestroni5, Joseph Cleveland6, James T Willerson7, Priyatansh Gurha1, Ali J Marian1. 1. From the Center for Cardiovascular Genetics, Department of Medicine, Institute of Molecular Medicine, Texas Heart Institute, University of Texas Health Sciences Center at Houston (S.M.C., P.G., A.J.M.). 2. Center for Cardiovascular Research, Washington University, School of Medicine, St Louis, MO (S.J.M.). 3. Baylor College of Medicine, Houston, TX (C.C., M.J.R.). 4. MD Anderson Cancer Center, Houston, TX (X.H.). 5. Division of Cardiology (M.S., M.T., L.M.), University of Colorado, Denver. 6. Division of Cardiothoracic Surgery (J.C.), University of Colorado, Denver. 7. Texas Heart Institute, Houston (J.T.W.).
Abstract
RATIONALE: LMNA (Lamin A/C), a nuclear membrane protein, interacts with genome through lamin-associated domains (LADs) and regulates gene expression. Mutations in the LMNA gene cause a diverse array of diseases, including dilated cardiomyopathy (DCM). DCM is the leading cause of death in laminopathies. OBJECTIVE: To identify LADs and characterize their associations with CpG methylation and gene expression in human cardiac myocytes in DCM. METHODS AND RESULTS: LMNA chromatin immunoprecipitation-sequencing, reduced representative bisulfite sequencing, and RNA-sequencing were performed in 5 control and 5 LMNA-associated DCM hearts. LADs were identified using enriched domain detector program. Genome-wide 331±77 LADs with an average size of 2.1±1.5 Mbp were identified in control human cardiac myocytes. LADs encompassed ≈20% of the genome and were predominantly located in the heterochromatin and less so in the promoter and actively transcribed regions. LADs were redistributed in DCM as evidenced by a gain of 520 and loss of 149 genomic regions. Approximately, 4500 coding genes and 800 long noncoding RNAs, whose levels correlated with the transcript levels of coding genes in cis, were differentially expressed in DCM. TP53 (tumor protein 53) was the most prominent among the dysregulated pathways. CpG sites were predominantly hypomethylated genome-wide in controls and DCM hearts, but overall CpG methylation was increased in DCM. LADs were associated with increased CpG methylation and suppressed gene expression. Integrated analysis identified genes whose expressions were regulated by LADs or CpG methylation, or by both, the latter pertained to genes involved in cell death, cell cycle, and metabolic regulation. CONCLUSIONS: LADs encompass ≈20% of the genome in human cardiac myocytes comprised several hundred coding and noncoding genes. LADs are redistributed in LMNA-associated DCM in association with markedly altered CpG methylation and gene expression. Thus, LADs through genomic alterations contribute to the pathogenesis of DCM in laminopathies.
RATIONALE: LMNA (Lamin A/C), a nuclear membrane protein, interacts with genome through lamin-associated domains (LADs) and regulates gene expression. Mutations in the LMNA gene cause a diverse array of diseases, including dilated cardiomyopathy (DCM). DCM is the leading cause of death in laminopathies. OBJECTIVE: To identify LADs and characterize their associations with CpG methylation and gene expression in human cardiac myocytes in DCM. METHODS AND RESULTS:LMNA chromatin immunoprecipitation-sequencing, reduced representative bisulfite sequencing, and RNA-sequencing were performed in 5 control and 5 LMNA-associated DCM hearts. LADs were identified using enriched domain detector program. Genome-wide 331±77 LADs with an average size of 2.1±1.5 Mbp were identified in control human cardiac myocytes. LADs encompassed ≈20% of the genome and were predominantly located in the heterochromatin and less so in the promoter and actively transcribed regions. LADs were redistributed in DCM as evidenced by a gain of 520 and loss of 149 genomic regions. Approximately, 4500 coding genes and 800 long noncoding RNAs, whose levels correlated with the transcript levels of coding genes in cis, were differentially expressed in DCM. TP53 (tumor protein 53) was the most prominent among the dysregulated pathways. CpG sites were predominantly hypomethylated genome-wide in controls and DCM hearts, but overall CpG methylation was increased in DCM. LADs were associated with increased CpG methylation and suppressed gene expression. Integrated analysis identified genes whose expressions were regulated by LADs or CpG methylation, or by both, the latter pertained to genes involved in cell death, cell cycle, and metabolic regulation. CONCLUSIONS: LADs encompass ≈20% of the genome in human cardiac myocytes comprised several hundred coding and noncoding genes. LADs are redistributed in LMNA-associated DCM in association with markedly altered CpG methylation and gene expression. Thus, LADs through genomic alterations contribute to the pathogenesis of DCM in laminopathies.
Entities:
Keywords:
DNA methylation; cardiomyopathies; chromatin immunoprecipitation; gene expression; genomics
Authors: Joseph M Zullo; Ignacio A Demarco; Roger Piqué-Regi; Daniel J Gaffney; Charles B Epstein; Chauncey J Spooner; Teresa R Luperchio; Bradley E Bernstein; Jonathan K Pritchard; Karen L Reddy; Harinder Singh Journal: Cell Date: 2012-06-22 Impact factor: 41.582
Authors: Lars Guelen; Ludo Pagie; Emilie Brasset; Wouter Meuleman; Marius B Faza; Wendy Talhout; Bert H Eussen; Annelies de Klein; Lodewyk Wessels; Wouter de Laat; Bas van Steensel Journal: Nature Date: 2008-05-07 Impact factor: 49.962
Authors: Jop Kind; Ludo Pagie; Havva Ortabozkoyun; Shelagh Boyle; Sandra S de Vries; Hans Janssen; Mario Amendola; Leisha D Nolen; Wendy A Bickmore; Bas van Steensel Journal: Cell Date: 2013-03-21 Impact factor: 41.582
Authors: D Fatkin; C MacRae; T Sasaki; M R Wolff; M Porcu; M Frenneaux; J Atherton; H J Vidaillet; S Spudich; U De Girolami; J G Seidman; C Seidman; F Muntoni; G Müehle; W Johnson; B McDonough Journal: N Engl J Med Date: 1999-12-02 Impact factor: 91.245
Authors: Benjamin P Berman; Daniel J Weisenberger; Joseph F Aman; Toshinori Hinoue; Zachary Ramjan; Yaping Liu; Houtan Noushmehr; Christopher P E Lange; Cornelis M van Dijk; Rob A E M Tollenaar; David Van Den Berg; Peter W Laird Journal: Nat Genet Date: 2011-11-27 Impact factor: 38.330
Authors: Hazel A Cruickshanks; Tony McBryan; David M Nelson; Nathan D Vanderkraats; Parisha P Shah; John van Tuyn; Taranjit Singh Rai; Claire Brock; Greg Donahue; Donncha S Dunican; Mark E Drotar; Richard R Meehan; John R Edwards; Shelley L Berger; Peter D Adams Journal: Nat Cell Biol Date: 2013-11-24 Impact factor: 28.824
Authors: Sirisha M Cheedipudi; Jinzhu Hu; Siyang Fan; Ping Yuan; Jennifer Karmouch; Grace Czernuszewicz; Matthew J Robertson; Cristian Coarfa; Kui Hong; Yan Yao; Hanna Campbell; Xander Wehrens; Priyatansh Gurha; Ali J Marian Journal: Cardiovasc Res Date: 2020-05-01 Impact factor: 10.787
Authors: Chia Yee Tan; Jing Xuan Wong; Pui Shi Chan; Hansen Tan; Dan Liao; Weiming Chen; Lek Wen Tan; Matthew Ackers-Johnson; Hiroko Wakimoto; Jonathan G Seidman; Christine E Seidman; Ida Gjervold Lunde; Feng Zhu; Qidong Hu; Jinsong Bian; Jiong-Wei Wang; Roger S Foo; Jianming Jiang Journal: Circ Res Date: 2019-09-09 Impact factor: 17.367
Authors: Chrishan J A Ramachandra; Jasper Chua; Shuo Cong; Myu Mai Ja Kp; Winston Shim; Joseph C Wu; Derek J Hausenloy Journal: Cardiovasc Res Date: 2021-02-22 Impact factor: 10.787
Authors: Parisha P Shah; Wenjian Lv; Joshua H Rhoades; Andrey Poleshko; Deepti Abbey; Matthew A Caporizzo; Ricardo Linares-Saldana; Julie G Heffler; Nazish Sayed; Dilip Thomas; Qiaohong Wang; Liam J Stanton; Kenneth Bedi; Michael P Morley; Thomas P Cappola; Anjali T Owens; Kenneth B Margulies; David B Frank; Joseph C Wu; Daniel J Rader; Wenli Yang; Benjamin L Prosser; Kiran Musunuru; Rajan Jain Journal: Cell Stem Cell Date: 2021-02-01 Impact factor: 24.633
Authors: Julien L P Morival; Halida P Widyastuti; Cecilia H H Nguyen; Michael V Zaragoza; Timothy L Downing Journal: Clin Epigenetics Date: 2021-07-10 Impact factor: 7.259